

Development of trivalent combination vaccines against diphtheria, tetanus, and pertussis (DTaP); Penta/hexa-valent vaccines against haemophilus influenza type B(HiB), polio(IPV), hepatitis B =(HepB), etc.
Ensuring advanced vaccine technologies by revamping the safety and the production process
Development of vaccines with improved efficacy and stability
Development of vaccines against metastatic cancer-related diseases, including cervical cancer and head and neck cancer